Clik here to view.
パスウェイ・ゲノミクス、PALB2検査可能なBreastTrue NGSハイリスク乳がんパネルを発表
サンディエゴ （ビジネスワイヤ） — 米サンディエゴに拠点を置き、CLIAおよびCAPの認定を受けて遺伝子検査サービスを世界規模で提供している臨床ラボラトリーのパスウェイ・ゲノミクス・コーポレーションは本日、...
View ArticleClik here to view.
ProNova SC360 Selected for New Proton Center in Biopolis Singapore
KNOXVILLE, Tenn. Singapore Institute of Advanced Medicine Holdings Pte Ltd (SAM) and ProNova announced today that ProNova has been selected by SAM as its partner to establish the first proton...
View ArticleClik here to view.
BeiGene Receives Clinical Milestone Payment for Development of BGB-290
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the...
View ArticleClik here to view.
Panagene Succeeds in Developing ‘ctDNA Mutation Test’ KitLaunching a Total of...
SEOUL, South Korea Panagene has been in focus on news of having developed a commercial ctDNA test kits that can detect mutated oncogene through blood test alone. This technology is based on PNA...
View ArticleClik here to view.
Merck Serono to Broaden Its General Medicines Portfolio in Emerging Markets...
DARMSTADT, Germany Merck Serono, the biopharmaceutical division of Merck, today announced the establishment of a long-term strategic partnership with Lupin Limited (Lupin), India. Lupin will support...
View ArticleClik here to view.
Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI...
HENDERSON, Nev. & ROCKVILLE, Md. Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in...
View ArticleClik here to view.
Telormedix Granted European Patent for Vesimune
BIOGGIO, Switzerland Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and infectious diseases, announced today that it has been granted the...
View ArticleClik here to view.
Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing...
DEERFIELD, Ill. & CAMBRIDGE, Mass. Baxter International Inc. (NYSE:BAX) and Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today jointly announced an exclusive license and collaboration agreement...
View ArticleClik here to view.
NCKU Research Team Reveals Key Mechanism in Lung Cancer
TAINAN, Taiwan Lung cancer remains one of the most common and malignant cancers worldwide. A Tainan-based research team from National Cheng Kung University (NCKU) has discovered Rab37, a protein in...
View ArticleClik here to view.
Blaze Bioscience Announces Initiation of Phase 1b Brain Cancer Program for...
SEATTLE Blaze Bioscience, Inc., a biotechnology company focused on guided cancer therapy, announced today that the company has received clearance from the United States Food and Drug Administration...
View ArticleClik here to view.
PharmaEngine and Merrimack Amend MM-398 License Agreement
TAIPEI, Taiwan PharmaEngine, Inc. (TWO: 4162), announced today that the company has signed an Amendment to its License Agreement of MM-398 (aka PEP02, nanoliposomal irinotecan injection, nal-IRI)...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA...
BOTHELL, Wash. & OSAKA, Japan Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received...
View ArticleClik here to view.
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Kyowa Hakko Kirin (Tokyo:4151), announced today that they have entered into an agreement to explore the therapeutic potential of the combination of...
View ArticleClik here to view.
BioJapan 2014 World Business Forum 出展企業プロフィール
横浜 （ビジネスワイヤ） – BioJapan 2014 World Business Forumが、2014年10月15日（水）～ 17（金）に、パシフィコ横浜（横浜市西区）で開催されます。 ビジネスワイヤはBioJapan...
View ArticleClik here to view.
BioJapan 2014 World Business Forum Exhibitor Profiles
YOKOHAMA, Japan BioJapan 2014 World Business Forum takes place October 15 – 17 at the PACIFICO YOKOHAMA in Yokohama, Japan. Business Wire is the official media partner for the BioJapan 2014....
View ArticleClik here to view.
GE Healthcare Study: Most People Unaware that Women with High Breast Density...
CHALFONT ST GILES, England Three out of four people are not aware that dense breast tissue increases a woman’s risk of developing breast cancer, 1, 2 according to a new global study from GE...
View ArticleClik here to view.
【 BioJapan 】 － アジア最大級のバイオ総合展 －世界のバイオ企業が日本に熱視線！ビッグファーマ・ベンチャー・アカデミアが創る新バイオビジネス
東京 （ビジネスワイヤ） — 来る2014年10月15日（水）～17日（金）の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2014 – World Business Forum – を開催します。 BioJapan...
View ArticleClik here to view.
EDPバイオテックが大腸がん早期発見に資するインビトロ診断ツールColoMarkerのCEマーク認証取得と欧州での商業化計画を発表
米テネシー州ノックスビル （ビジネスワイヤ） —...
View ArticleClik here to view.
DNA Sequencing HPV Testing and Pap Smears Necessary for Optimum Patient Care,...
MILFORD, Conn. Sin Hang Lee, M.D., a Milford (Conn.) Hospital pathologist and lead author of “From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice,” a...
View ArticleClik here to view.
Seattle Genetics与武田发布 ADCETRIS® (Brentuximab...
华盛顿州博瑟尔和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)今天宣布，自体干细胞移植(ASCT)后立即接受ADCETRIS (brentuximab...
View Article